Tekcapital appoints Dr Robert Miller to its Board as Non-Executive Director

– UK, Oxford – Tekcapital plc (AIM: TEK), an international provider of technology and intellectual property services, announces that Robert Clell Miller, M.D., has been appointed to the Company’s Board as a Non-Executive Director with immediate effect.

Dr. Miller is Vice Chairman of the Board of Trustees of Mayo Clinic Health System – Albert Lea and Austin.

Dr. Miller is also a Professor of Radiation Oncology at Mayo Clinic Jacksonville and is also Medical Director of Mayo Clinic’s Operations in Northfield. Dr. Miller has over 20 years’ experience in Radiation Oncology and is currently Editor in Chief of the Rare Tumours medical journal in Italy and the Advances in Radiation Oncology medical journal in the USA.

In addition to a medical degree from the University of Kentucky, Dr. Miller has undergraduate degrees in Business Administration and Engineering Physics from the University of Tulsa, a master’s degree in Radiological Medical Physics from the University of Kentucky and an MBA from the University of Oxford, UK.

Clifford M. Gross, Executive Chairman of Tekcapital, said: “We are delighted to add Dr. Miller to the Board and believe his addition will provide significant business, medical and scientific expertise for future evaluations of medical technology and their opportunities for industrial scale commercialisation”.

About Tekcapital plc

Tekcapital helps clients profit from new, university-developed intellectual properties. With our proprietary discovery search engine, linked to 4,000+ universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP they need to create a competitive advantage. Tekcapital plc is listed on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK.

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

here, the original post =>